BioCentury
ARTICLE | Company News

Cizzle Biotechnology, Fujirebio deal

May 27, 2013 7:00 AM UTC

Cizzle and Fujirebio's Fujirebio Diagnostics Inc. will co-develop Cizzle's blood test that detects a variant of CDKN1A interacting zinc finger protein 1 (CIZ1) to diagnose early stage lung cancers. T...